Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations

被引：0
|
作者：
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Lv, W. [1 ]
Hu, J. [1 ]
Ye, J. [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Aumolertinib; Adjuvant; Uncommon EGFR mutations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07E.07
引用
收藏
页码：S555 / S556
页数：2
相关论文
共 50 条
  • [31] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer. A retrospective study with cisplatin or carboplatin and oral vinorelbin
    Engel-Riedel, W.
    Magnet, F.
    Alten, N.
    Ludwig, C.
    Bachinger, A.
    Stoelben, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 86 - 86
  • [32] S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancer
    Okuda, Katsuhiro
    Yano, Motoki
    Tatematsu, Tsutomu
    Nakamae, Katsumi
    Yamada, Takeshi
    Kasugai, Toshio
    Nishida, Tsutomu
    Sano, Masaaki
    Moriyama, Satoru
    Haneda, Hiroshi
    Kawano, Osamu
    Nakanishi, Ryoichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 73 - 79
  • [33] Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
    Pisters, Katherine
    Kris, Mark G.
    Gaspar, Laurie E.
    Ismaila, Nofisat
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (10) : 1127 - +
  • [34] Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Pirker, Robert
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (05) : 305 - 310
  • [35] Adjuvant chemotherapy for resected non-small-cell lung cancer - ANITA takes the stage
    Azzoli, Christopher G.
    LANCET ONCOLOGY, 2006, 7 (09): : 701 - 703
  • [36] Adjuvant therapy of resected non-small-cell lung cancer
    Keller, SM
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (02) : 149 - 155
  • [37] Adjuvant chemotherapy for resected non-small-cell lung cancer
    Solomon, Benjamin
    Mitchell, John D.
    Bunn, Paul A., Jr.
    ONCOLOGY-NEW YORK, 2005, 19 (13): : 1685 - 1697
  • [38] Randomized Feasibility Study of S-1 for Adjuvant Chemotherapy in Completely-Resected Stage IA Non-Small-Cell Lung Cancer (SLCG 0701)
    Okumura, Norihito
    Soh, Junichi
    Nakata, Masao
    Nakamura, Hiroshige
    Fukuda, Minoru
    Kataoka, Masafumi
    Kajiwara, Shinsuke
    Sano, Yoshifumi
    Aoe, Motoi
    Kataoka, Kazuhiko
    Hotta, Katsuyuki
    Matsuo, Keitaro
    Toyooka, Shinichi
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S440 - S441
  • [39] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    LANCET ONCOLOGY, 2010, 11 (05): : 412 - 413
  • [40] Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer Reply
    Wu, Yi-Long
    Zhong, Wen-Zhao
    LANCET ONCOLOGY, 2018, 19 (03): : E127 - E127
12345